Ilex Capital Partners (Uk) LLP Bio Rad Laboratories, Inc. Transaction History
Ilex Capital Partners (Uk) LLP
- $3.02 Trillion
- Q2 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 120,885 shares of BIO stock, worth $33.2 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
120,885
Previous 6,395
1790.3%
Holding current value
$33.2 Million
Previous $1.56 Billion
1772.92%
% of portfolio
0.97%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
427Shares Held
19.1MCall Options Held
10.7KPut Options Held
37.5K-
First Eagle Investment Management, LLC2.52MShares$692 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$507 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$426 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$275 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$237 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.77B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...